NASDAQ:AVTX

Avalo Therapeutics Stock Predictions

etoro logo Buy AVTX
*Your capital is at risk
$13.74
-0.220 (-1.58%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AVTX Prediction Chart

AVTX Predictions History

Latest community submissions for AVTX.
Predictor Target Session Target Price Result Direction Accuracy Score
SonaCortado SonaCortado Merchant
Sep 20, 2023 $0.119 -99.59% $0.111 V 93.18% 1
JS JS Pro
Sep 20, 2023 $0.139 -99.53% $0.111 X 75.22% 0
Sep 20, 2023 $0.141 -99.52% $0.111 X 73.07% 0
Sep 20, 2023 $0.134 -99.54% $0.111 X 79.77% 0
AlexVel AlexVel Pro
Jun 29, 2023 $0.568 -99.44% $0.370 X 46.53% 0
JS JS Pro
Jun 29, 2023 $0.513 -99.50% $0.370 X 61.35% 0
Jun 29, 2023 $0.678 -99.34% $0.370 X 16.64% 0
Jun 29, 2023 $0.584 -99.43% $0.370 X 42.19% 0
JS JS Pro
Jun 27, 2023 $0.675 -99.44% $0.430 X 43.02% 0
Jun 27, 2023 $0.785 -99.35% $0.430 X 17.39% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AVTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AVALO THERAPEUTICS, INC.
Avalo Therapeutics
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE